Bristol-Myers Squibb Brazil

Last updated: 13.02.2014

Address: RUA CARLOS GOMES, 924 SANTO AMARO – CEP 04743-903 SÃO PAULO – SP,Brazil

Tel: 11 3882-2000

Web: http://www.bristol.com.br/Home.aspx

Company description

Bristol-Myers Squibb in over 60 years of presence in the country, has built a solid and positive relationship with Brazil. More than a strategic market for the company, the country has been contributing to the uneven development and actively participating in the development of its history.

Bristol-Myers Squibb Brazil aims to be protagonists in the transformation of the global pharmaceutical industry that invests in the creation of drugs from living cells.

In addition, Bristol-Myers Squibb Brazil is also positioning itself in the development and commercialization of drugs for the treatment of complex diseases with a focus on products for diseases where no alternative treatments are available.
Bristol-Myers Squibb Brazil is one of the most promising pharmaceutical companies worldwide, possessing one of the most important pipelines.
For patients and medical Bristol-Myers Squibb Brazil has also contributed significantly through the launch of seven new products since 2001. Four addtional new products should reach the market by 2012, including the Brazilian market.

The company’s main areas are: oncology, virology, immunology, neurology and cardiovascular disease. The company last year invested more than $ 3.5 billion in research to develop new drugs. It is worth noting that some of these funds were allocated to more than 500 research centers in Brazil that are partners in major development projects of the company.

Bristol-Myers Squibb Brazil is commited to the whole of Brazilian society to continue their core mission, to discover, develop and deliver innovative medicines that help patients overcome serious illness.

Products and services

ABILIFY®, ATRIPLA®, COUMADIN®, PLAVIX®, YERVOY™

Interviews

Related

We use cookies to ensure that we give you the best experience on our site. For more info click here